Lenvatinib plus everolimus (LenEve) in patients with pre-treated advanced renal cell carcinoma (mRCC): Real world evidence (Relevance) von Ivanyi, Philipp, Eggers, Hendik, Stelmach, Ramona, Boegemann, Martin, Strauß, Arne, Thomas, Christian, Landmesser, Johannes, Kramer, Mario W, Zschaebitz, Stefanie

Volltext

Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up von Stelmach, Ramona, Apostolidis, Leonidas, Kahle, Steffen, Sisic, Leila, Nienhüser, Henrik, Weber, Tim Frederik, Jäger, Dirk, Haag, Georg Martin

Volltext

Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination von Aydogdu, Can, Paffenholz, Pia, Stelmach, Ramona, Schlack, Katrin, Roghmann, Florian, Handke, Analena, Mandal, Subhajit, Schnabel, Marco, Merseburger, Axel, Ivanyi, Philipp, Zschaebitz, Stefanie, Darr, Christopher, Grünwald, Viktor, Stief, Christian G., Casuscelli, Jozefina

Volltext

Treatment options and outcome of patients with metastatic renal cell carcinoma with brain or bone metastases: Real world evidence from a German retrospective multi-center analysis von Paffenholz, Pia, Ivanyi, Philipp, Casuscelli, Jozefina, Stelmach, Ramona, Guer, Melis, Schlack, Katrin, Darr, Christopher, Rinderknecht, Emily, Hilser, Thomas, Flegar, Luka, Klee, Melanie, Seidl, Daniel, Handke, Analena, Nestler, Tim, Mattigk, Angelika, Augustin, Marinela, Hijazi, Sameh, Rehlinghaus, Marc, Heidenreich, Axel, Gruenwald, Viktor

Volltext